Affiliation:
1. Department of Pediatric Pneumonology and Allergy Medical University of Warsaw Warsaw Poland
2. Department of Epidemiology and Biostatistics Medical University of Warsaw Warsaw Poland
3. Department of Internal Medicine, Pulmonary Diseases and Allergy Medical University of Warsaw Warsaw Poland
Abstract
AbstractBackgroundNeuroendocrine cell hyperplasia of infancy (NEHI) is a form of childhood interstitial lung disease of unknown origin associated with hyperplasia of pulmonary neuroendocrine cells (PNECs). Diagnosis is based on the characteristic clinical picture and typical radiological imaging, and, in some cases, on lung biopsies. To date, no biochemical indicators of the disease have been identified.AimWe aimed to determine biomarkers that could be useful in the management of children diagnosed with NEHI.MethodsPatients with NEHI and healthy children were enrolled. Concentrations of serum biomarkers secreted by PNECs (calcitonin gene‐related peptide and gastrin‐releasing peptide) and biomarkers of the destruction of alveolar capillary membrane (surfactant proteins A and D [SP‐A and SP‐D]; glycoprotein Krebs von den Lungen‐6 [KL‐6]; metalloproteinases 7 and 9 [MMP‐7 and MMP‐9]; tissue inhibitor of metalloprotease 1) were measured.ResultsFifty‐two children with NEHI and 23 healthy children were included in the study. The median age of children with NEHI was 3.9 years. There were no differences in serum levels of biomarkers secreted by PNECs between groups. KL‐6 levels were significantly higher in children with NEHI than in healthy ones (median 119.6 vs. 92.1 U/mL, p = 0.003); however, concentrations of KL‐6 were low in both groups. No significant differences existed between groups for the remaining biomarkers associated with the destruction of the alveolar‐capillary membrane.ConclusionsMeasurement of serum biomarkers released by PNECs and those associated with the destruction of the alveolar‐capillary membrane does not appear to be useful in the management of children with NEHI.